Neurim, Pharmaceuticals

Neurim Pharmaceuticals recibe la opinión positiva del CHMP sobre Slenyto®

Published on 08/07/2025 at 18:07 | prnewswire.co.uk

Neurim Pharmaceuticals Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom Israel United States of America Canada Australia South Korea

View original content:https://www.prnewswire.com/news-releases/neurim-pharmaceuticals-recibe-la-opinion-positiva-del-chmp-sobre-slenyto-302209470.html

en | boerse | 67939058 |